论文部分内容阅读
最近两年,世界制药产业面临的两个最紧迫的问题是创新萎靡不振和大量品名药的专利保护到期,这一形势对素来以高强度高效率的研发和严密的专利保护赖以生存的跨国制药公司来说,关乎命运。为此,跨国公司在破解创新迷局、跻身非专利药市场、拓展新的市场疆域方面出手了一系列的
In the recent two years, the two most pressing problems facing the pharmaceutical industry in the world are the prolonged innovation and the expiration of the patent protection of a large number of drugs, a situation that has always been to rely on high-intensity and high-efficiency research and development and strict patent protection Transnational pharmaceutical companies, the fate of. To this end, multinational corporations have taken a series of efforts in breaking the innovation puzzle, entering the generic drug market and expanding new market boundaries